Litcius/Paper detail

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor

Elisabeth Bou‐Petit, Stefan Hümmer, Helena Alarcon, Konstantin Slobodnyuk, Marta Cano-Galietero, Pedro Juan Barrios Fuentes, Pedro J. Guijarro, María José Muñoz, Leticia Suárez‐Cabrera, Anna Santamaría, Roger Estrada‐Tejedor, José I. Borrell, Santiago Ramón y Cajal

2022Journal of Medicinal Chemistry15 citationsDOIOpen Access PDF

Abstract

represents therefore a promising starting point for the development of a novel generation of MNK inhibitors.

Topics & Concepts

ChemistryKinaseMode of actionCell biologySmall moleculeCancer researchRational designComputational biologyBiochemistryPharmacologyBiologyGeneticsMelanoma and MAPK PathwaysProtein Tyrosine PhosphatasesProtein Kinase Regulation and GTPase Signaling
Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor | Litcius